Posted on 3/5/18
Amarin Announces Closing of Underwriter’s Purchase of Additional Shares
BEDMINSTER, N.J., and DUBLIN, Ireland, March 05, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that, in connection with its previously announced underwritten public . . .
Posted on 3/5/18
Onconova Therapeutics Announces License Agreement with Pint Pharma
NEWTOWN, Pa., March 05, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat . . .
Posted on 3/5/18
Celgene: Parsing The Ozanimod Debacle
Source: European Pharmaceutical ReviewCelgene (CELG) gave the market some bad news earlier this week. The company announced it received a Refusal To File ("RTF") letter from . . .
Posted on 3/2/18
Trevena Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CHESTERBROOK, Pa., March 02, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced that the independent Compensation Committee of the Board of Directors of the Company . . .
Posted on 3/2/18
Celgene's $6 Billion Blunder: Time to Throw in the Towel on the Biotech Stock?
When Celgene (NASDAQ:CELG) makes a mistake, it's a doozy.The big biotech reported on Tuesday that it had received a Refusal to File letter from the U.S. . . .
Posted on 3/2/18
Protalex Announces Completion of $1.425 Million Private Placement
FLORHAM PARK, N.J.--(BUSINESS WIRE)--Protalex, Inc. (OTCQB: PRTX), a clinical-stage biopharmaceutical company, today announced that on February 28, 2018, it consummated a private placement financing to accredited . . .
Posted on 3/1/18
Genesis HealthCare Regains Compliance With NYSE Continued Listing Standard
KENNETT SQUARE, Pa., March 01, 2018 (GLOBE NEWSWIRE) -- Genesis HealthCare (NYSE:GEN), one of the nation’s largest providers of post-acute care, today announced that it received . . .
Posted on 3/1/18
Celgene's Run of Bad Luck Continues
Eager to diversify its revenue away from multiple myeloma treatments, Celgene(NASDAQ:CELG)spent $7.2 billion in 2015 to acquire the promising multiple sclerosis drug candidate ozanimod. Then, it . . .
Posted on 3/1/18
Safeguard Scientifics Announces Fourth Quarter And Full-Year 2017 Financial Results
Safeguard Scientifics, Inc. (NYSE: SFE) ("Safeguard" or the "Company") today announced financial results for the three months and 12 months ended December 31, 2017 and provided . . .
Posted on 3/1/18
J&J Will Continue To Suffer As Long As Scott Gottlieb Is In Charge Of The FDA
Generics, genericsThe FDA under Scott Gottlieb is pushing for increased generic competition in order to drive drug prices down. Major steps have been taken in pursuit . . .
Posted on 3/1/18
Zelis Healthcare Wins Four Stevie Awards For Sales & Customer Service
BEDMINSTER, N.J.--(BUSINESS WIRE)--Zelis® Healthcare, a market-leading provider of integrated healthcare cost management and payments solutions, was presented with three Silver Stevies®, one Bronze Stevie and a . . .
Posted on 2/28/18
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on February 26, 2018 it approved non-statutory stock options to purchase an aggregate of 96,750 shares of its . . .
Posted on 2/28/18
Alamo Pharma Services Recognized by Training Magazine asa 2018 Training Top 125 Winner
DOYLESTOWN, Pa., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Alamo Pharma Services (“Alamo”) was recently recognized as one of Training magazine’s annual Training Top 125, that ranks . . .
Posted on 2/28/18
Johnson & Johnson Still Showing Geron Much Love
With days or weeks before the final interim review for Geron's (GERN) Imetelstat in the iMbark Myelofibrosis "MF" trial, its time for investors to consider the . . .
Posted on 2/28/18
Johnson & Johnson Might Seal The Deal With Geron This Year
Investment ThesisWith days or weeks before the final interim review for Geron's (GERN) Imetelstat in the iMbark Myelofibrosis "MF" trial, its time for investors to consider . . .
Posted on 2/27/18
PhaseBio Awarded $2.8 Million NIH SBIR Grant
MALVERN, Pa., Feb. 27, 2018 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing therapies for the treatment of orphan diseases, today announced that . . .
Posted on 2/27/18
SteroTherapeutics Announces Closing of Financing
PHILADELPHIA, Feb. 27, 2018 (GLOBE NEWSWIRE) -- SteroTherapeutics, a privately held biopharmaceutical company developing metabolic-based therapies focused on non-alcoholic steatohepatitis (NASH), announced today the recent completion . . .
Posted on 2/26/18
Centric Bank Announces Exclusive Practice Financing Partnership with the Pennsylvania Dental Association
Centric Financial Corporation, Inc., (CFCX), has entered into an exclusive endorsed practice financing partnership with the Pennsylvania Dental Association (PDA) and Pennsylvania Dental Association Insurance Services . . .
Posted on 2/26/18
Teva: Berkshire Thinks Bondholders Are 'Mullet Mullet'
Warren Buffett of Berkshire Hathaway. Source: medium.comTeva (TEVA) has been reeling since Mylan's (MYL) generic Copaxone was approved Q4 2017. Having one's most-profitable drug go generic . . .
Posted on 2/23/18
Would Pfizer Investors Win With a Bristol-Myers Squibb Acquisition?
You can almost hear the sound of keyboards at Pfizer's (NYSE:PFE) headquarters in New York crunching the numbers on potential deals. The giant drugmaker was eerily . . .
Posted on 2/23/18
Advaxis Prices $20.0 Million Public Offering of Common Stock
PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis, Inc. (NASDAQ:ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of cancer immunotherapies, announced today the pricing of its previously . . .
Posted on 2/22/18
Can Johnson & Johnson Replace Remicade for $100 Million Upfront?
As huge piles of overseas cash make their way back to big U.S. drugmakers, biotech buyoutsdominate the headlines. While most of us were watching the big . . .
Posted on 2/22/18
Genesis Announces New Financing Commitments and Provides Updates to Previously Announced Restructuring Plans
KENNETT SQUARE, Pa., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Genesis HealthCare (NYSE:GEN) (Genesis or the Company), one of the nation’s largest providers of post-acute care, today . . .
Posted on 2/21/18
Glenmark Pharmaceuticals Enters Exclusive Collaboration Agreement with SCD Pharmaceuticals
Glenmark Pharmaceuticals, a global pharmaceutical company, today announced it has entered into an exclusive agreement with Sam Chun Dang Pharm. Co. Ltd. (SCD), to develop, manufacture . . .
Posted on 2/21/18
Amicus Therapeutics Announces Closing of Underwritten Offering of Common Stock
CRANBURY, N.J., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD) today announced the closing of its previously announced offering of common stock. The Company issued . . .

